Cloudbreak Pharma Inc. (Stock Code: 02592) has scheduled a board meeting for Monday, 30 March 2026. Key agenda items include:

• Approval of the Group’s audited annual results for the financial year ended 31 December 2025. • Deliberation on the recommendation of a final dividend, if any, for the period under review.

The meeting will be chaired by Dr. Ni Jinsong, who serves as Chairman, Executive Director and Chief Executive Officer. The current Board structure comprises:

• Executive Directors: Dr. Ni Jinsong, Mr. Dinh Son Van, Dr. Yang Rong. • Non-Executive Directors: Dr. Li Jun Zhi, Mr. Cao Xu, Mr. Xia Zhidong. • Independent Non-Executive Directors: Ms. Nie Sijiang, Mr. Ma Yiu Ho Peter, Mr. Lee Alex Jao Jang.

The announcement was released in Hong Kong on 18 March 2026.